Furthermore, a similar observation also found in the evaluation the use of diabetic drugs with a cumulative defined daily dose (cDDD) (Table 3), with risk of developing AD in each cDDD subgroup as the following order: pioglitazone plus insulin group > pioglitazone alone group > insulin alone group. The gene discussed is INS; the disease is Alzheimer disease.